Global challenges in breast cancer detection and treatment
Carlos H Barrios DOI: 10.1016/j.breast.2022.02.003 Full link: https://www.thebreastonline.com/article/S0960-9776(22)00030-3/fulltext
Effects of capecitabine as part of neo-/adjuvant chemotherapy – A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients
Marion T van Mackelenbergh, Fenja Seither, Volker Möbus, Joyce O'Shaughnessy, Miguel Martin, Heikki Joensuu, Michael Untch, Ulrike Nitz, Guenther G Steger, Juan J Miralles, Carlos H Barrios, Masakazu Toi, Harry D Bear, Hyman Muss, Toralf Reimer, Valentina Nekljudova, Sibylle Loibl DOI: 10.1016/j.ejca.2022.02.003 Full link: https://www.ejcancer.com/article/S0959-8049(22)00076-4/fulltext
Moderate hypofractionation for salvage radiotherapy (HYPO-SRT) in patients with biochemical recurrence after prostatectomy: A cohort study with meta-analysis
Gustavo Arruda Viani, Andre Guimaraes Gouveia, Elton Trigo Teixeira Leite, Fabio Ynoe Moraes DOI: 10.1016/j.radonc.2022.03.006 Full link: https://pubmed.ncbi.nlm.nih.gov/35288228/
Moderate hypofractionation for salvage radiotherapy (HYPO-SRT) in patients with biochemical recurrence after prostatectomy: A cohort study with meta-analysis
Gustavo Arruda Viani, Andre Guimaraes Gouveia, Elton Trigo Teixeira Leite, Fabio Ynoe Moraes DOI: 10.1016/j.radonc.2022.03.006 Full link: https://pubmed.ncbi.nlm.nih.gov/35288228/
Characteristics of patients diagnosed with cervical cancer in Brazil: preliminary results of the prospective cohort EVITA study (EVA001/LACOG 0215)
Angélica Nogueira Rodrigues, Andréia Cristina de Melo, Aknar Freire de Carvalho Calabrich, Eduardo Cronenberger, Kátia Luz Torres, Fernanda Damian, Rachel Cossetti, Carla Rameri Alexandre Silva de Azevedo, Allex Jardim da Fonseca, Yeni Nerón, João Nunes, André Lopes, Felipe Thomé, Renato Leal, Giuliano Borges, Arthur Ferreira da Silva, Matheus Füehr Rodrigues, Paulo Ricardo Santos Nunes Filho, Facundo Zaffaroni, Raquel Dal Sasso Freitas, Gustavo Werutsky, Fernando Maluf DOI: 10.1136/ijgc-2021-002972 Full link: https://ijgc.bmj.com/content/32/2/141
Moderately hypofractionated post-operative radiation therapy for breast cancer: Systematic review and meta-analysis of randomized clinical trials
Gustavo Nader Marta, Rachel Riera, Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Icro Meattini, Orit Kaidar-Person, Philip Poortmans DOI: 10.1016/j.breast.2022.01.018 Full link: https://linkinghub.elsevier.com/retrieve/pii/S096097762200025X
International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials
Matthew P Smeltzer, Giorgio V Scagliotti, Heather A Wakelee, Tetsuya Mitsudomi, Upal Basu Roy, Russell C Clark, Renee Arndt, Clayton D Pruett, Karen L Kelly, Peter Ujhazy, Melissa L Johnson , Yesim Eralp, Carlos H Barrios, Fabrice Barlesi, Fred R Hirsch, Paul A Bunn; DOI: 10.1016/j.jtho.2022.01.017 Full link: https://linkinghub.elsevier.com/retrieve/pii/S1556086422000867
The Lancet Summit: Cancer care in Asia and Latin America
July 14-15, 2022 | Online and On-Demand The Lancet Summit: Cancer care in Asia and Latin America will bring together key opinion leaders from across Asia and Latin America to highlight clinical and global oncology topics relevant for both regions in a post-pandemic world. The programme will encourage delegates to share experiences and learnings in both settings, foster interdisciplinary and multinational collaboration, and help inspire ideas to restore and improve cancer care and control. Topics include: Impact of COVID-19 on cancer care - future challenges and prioritiesHealth systems resiliencePalliative careCancer politics and policyNew technologies in cancer care Submissions are invited for contributed talks by February 18, 2022. To view the speakers and register visit: http://thelancetsummit.com/aosl
Innovation in Breast Cancer Symposium
The Innovation in Breast Cancer Symposium, will be held in online format on February 17th and 18th, 2022. The two-day international scientific program aims to provide state-of-the-art information on breast cancer, achieving a balance of clinical, translational, and basic research, as well as providing a forum for interaction, communication, and interdisciplinary education for specialists with a special interest in breast cancer. The registration period is now open. You can find all the information on the website through which you will have access to the registration section, general information, etc. Learn more: www.innovationinbreastcancer.com